DENVER BROWN: Open Payments
NPI 1508235557 · BRANSON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,125 in 60 payments from 12 companies in 2025. Trend: 2023 $1,356 · 2024 $1,041 · 2025 $1,125
Food & beverage: $1,125
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $381 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $184 |
| Lilly USA, LLC | 8 | $124 |
| ABBVIE INC. | 6 | $96 |
| Abbott Laboratories | 3 | $75 |
| Axsome Therapeutics, Inc. | 2 | $52 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $51 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
| Astellas Pharma US Inc | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
Products named: AIRSUPRA, CAPLYTA, FARXIGA, MOUNJARO, VRAYLAR, FREESTYLE LIBRE, REXULTI, Auvelity.
Industry payments across MO — which companies pay providers there.
